DOV Dover Corporation
A quality industrial compounder, but at 195 the price still assumes growth Dover has not delivered.
The story
Dover is a diversified industrial built around niche, engineered components (pumps, compression, clean energy fueling, refrigeration, marking/coding, biopharma connectors) where it holds strong share and pricing power. It is a mature compounder that adds growth through bolt-on acquisitions and portfolio pruning rather than organic expansion. TTM revenue of 8.42B (about 4% above last fiscal year) shows a modest cyclical recovery. Underlying margins of about 18% are solid; the 24.4% year was inflated by divestiture gains.
I kept the prior drivers because the facts have not materially changed. TTM growth of about 4% and an 18.1% margin support 5% near-term growth and a gradual move to 19.5% through mix and productivity. Sales-to-capital edges down from 0.82 to 0.80 to match the acquisition-heavy 0.78 TTM, a move well under the 20% threshold. Even with the price down to 195, the market is still pricing in growth or margins that the roughly 1% five-year revenue CAGR does not support.
Value drivers
| Revenue growth (Y1) | 5.0% |
| Terminal growth | 3.0% |
| Forecast horizon | 8y |
| Target operating margin | 19.5% |
| Years to target margin | 7 |
| Sales-to-capital | 0.80 |
| Beta | 1.07 |
| Failure probability | 1.0% |
| Cost of capital (WACC) | 9.3% |
| Terminal WACC | 9.0% |
Valuation bridge
| PV of explicit FCFF | 5.64B |
| PV of terminal value | 11.23B |
| Equity value | 15.06B |
| ÷ shares → per share | $111.86 |
Projected free cash flow to the firm
| Yr | Revenue | Growth | Margin | NOPAT | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | 8.84B | 5.0% | 18.3% | 1.29B | 526.29M | 768.10M | 703.07M |
| 2 | 9.26B | 4.7% | 18.5% | 1.37B | 521.02M | 848.77M | 711.13M |
| 3 | 9.67B | 4.4% | 18.7% | 1.45B | 512.52M | 932.96M | 715.48M |
| 4 | 10.07B | 4.1% | 18.9% | 1.52B | 500.69M | 1.02B | 716.23M |
| 5 | 10.46B | 3.9% | 19.1% | 1.60B | 485.47M | 1.11B | 713.50M |
| 6 | 10.83B | 3.6% | 19.3% | 1.67B | 466.85M | 1.20B | 707.46M |
| 7 | 11.19B | 3.3% | 19.5% | 1.74B | 444.84M | 1.30B | 698.29M |
| 8 | 11.52B | 3.0% | 19.5% | 1.79B | 419.50M | 1.37B | 677.41M |
Key risks
- Cyclical industrial and capex slowdown hitting short-cycle segments like refrigeration and compression
- Acquisition-driven growth that destroys value if purchase prices exceed returns on capital
- Margin pressure from tariffs, input costs, or weaker pricing power as inflation fades
Catalysts
- Organic growth acceleration from data center thermal, CO2 refrigeration, and biopharma connector demand
- Capital redeployment of divestiture proceeds into high-return bolt-ons or buybacks